Larimar Therapeutics Chief Development Officer Gopi Shankar acquires common shares worth $13,549
LRMR•Chief Development Officer Gopi Shankar purchased 5,000 Larimar Therapeutics shares at $2.7098 each, increasing his direct holdings to 81,443 shares.
1. Share purchase
Gopi Shankar purchased 5,000 shares of Larimar Therapeutics common stock at $2.7098 per share, bringing his direct holdings to 81,443 shares.
